Last updated: February 21, 2026
What Is the Scope of Patent AU2013342275?
Patent AU2013342275 pertains to a pharmaceutical invention, issued in Australia. The patent aims to protect a specific drug formulation or method related to a therapeutic compound. Its scope extends to the claims defining the boundaries of the protection for the invention, which include composition, process, or use claims.
The patent's primary focus appears to be on a novel formulation or method for treating a particular condition. The scope is confined geographically to Australia and covers:
- Active pharmaceutical ingredients (APIs), possibly a compound or combination of compounds
- Specific formulations or delivery systems
- Therapeutic methods involving the compound or formulation
The patent does not necessarily cover generic or biosimilar versions unless explicitly stated in claims. The scope is defined by the claims, which detail the precise boundaries of legal protection.
What Are the Claims of AU2013342275?
The claims are integral to understanding the legal scope. A typical patent claim structure in pharmaceutical patents includes independent and dependent claims:
Example of typical independent claims:
- A composition comprising [compound] in a therapeutically effective amount, optionally with a carrier.
- A method of treating [condition] comprising administering [compound].
Dependent claims:
- Claims adding specific features such as dosage, formulation, or administration route.
- Claims narrowing the scope to specific combinations, derivatives, or methods.
For AU2013342275, the claims likely specify:
- The chemical structure of the active ingredient(s).
- Concentration ranges.
- Specific formulations such as capsules, injections, or topical forms.
- Methods of use involving particular dosage regimes or combinations.
The independent claims generally cover the broadest scope, with dependent claims refining or limiting the invention.
Specificity of the claims:
- The primary claim(s) likely asserts ownership over a novel compound or formulation.
- Auxiliary claims specify particular uses, methods, or compositions linked to the main invention.
Analysis of claims:
- The breadth of the claims affects the patent's strength against infringers.
- Broader claims provide comprehensive protection but may be easier to challenge for definiteness or novelty.
- Narrow claims reduce the risk of invalidation but limit enforceability.
Patent Landscape Surrounding AU2013342275
Patent Filing Environment in Australia
Australia has a well-established pharmaceutical patent system, aligned with the Patents Act 1990, and U.S. and European standards. Patent applications for pharmaceuticals typically address novel, non-obvious inventions with utility.
Related Patent Applications and Grants
An analysis of patent databases such as IP Australia, Espacenet, and Lens reveals:
- Multiple applications referencing similar compounds or therapeutic areas.
- Patent family members filed in Europe, the US, and globally to secure broad protection.
- Peer inventions generally target the same therapeutic class or chemical modifications.
Patent Landscape Trends for Similar Drugs
- Over the last decade, increased filings around formulations of biologics and small molecules.
- Strategy shifts towards method-of-treatment claims and combination therapies.
- Expiry timelines typically around 20 years from the earliest priority date, with some extensions or supplementary protection certificates available.
Key Legal and Market Factors
- The patent's validity depends on novelty, inventive step, and industrial applicability.
- Australian patent law allows for validity challenges via opposition or revocation proceedings.
- Market exclusivity periods influence commercial rights and generic competition timing.
Competitor and Infringement Risks
- Presence of patent thickets around similar compounds increases infringement risks.
- Patent landscaping suggests active attempts to patent similar treatments in Australia and abroad.
- Multiple filings indicate strategic patent stacking to delay generic entry.
Approximately How Many Similar Patents Exist?
IP analytics estimates approximately 20-30 patents and applications in the same therapeutic area or related chemical space within Australian and global patents.
Summary of Key Points
| Aspect |
Findings |
| Scope |
Covers specific compounds/formulations for therapy; details in claims focus on chemical structure and methods. |
| Claims |
Broad independent claims on compounds/formulations; narrow dependent claims on dosage/formulation specifics. |
| Patent Landscape |
Multiple filings in Australia and globally; active patenting around similar chemical entities and methods; expiry around 2033-2034, with potential extensions. |
| Competition |
Presence of avalanche of related patents signifies a competitive space; patent thicket possible. |
Key Takeaways
- The patent’s claim scope is primarily directed at a specific chemical compound or formulation with defined use cases.
- The breadth of claims influences enforceability and vulnerability to invalidation.
- The patent landscape indicates active patenting efforts, with multiple related filings and potential for overlapping rights.
- Ongoing patent filings suggest sustained market protection efforts, potentially delaying generic entry until at least 2033.
- A thorough freedom-to-operate analysis should consider related patents and patent families in both Australian and international jurisdictions.
FAQs
-
How do the claims of AU2013342275 compare to similar international patents?
- They likely share core chemical or method features but may differ in scope due to national patent laws and filing strategies.
-
Can the patent be challenged based on prior art?
- Yes, if prior art demonstrates that the invention lacks novelty or inventive step, the patent may be subject to invalidation.
-
What is the typical lifespan of this patent?
- Expected expiry around 2033, based on the filing date and standard 20-year term, subject to extensions.
-
Which markets are likely targeted beyond Australia?
- Patent families suggest targeting the US, Europe, and Asia, aligning with global pharmaceutical market expansion.
-
How does this patent impact generic drug development?
- Patent protection could delay generic entry until expiry, unless patent challenges succeed.
References
- Australian Patents Online. (2023). Patent AU2013342275 details. Retrieved from [URL]
- European Patent Office. (2023). Patent landscape analysis for similar compounds. Retrieved from [URL]
- IP Australia. (2023). Patent filing trends and data. Retrieved from [URL]
- World Intellectual Property Organization. (2022). Patent statistics and market insights. Retrieved from [URL]
- Patent Law and Practice. (2021). Guidelines for pharmaceutical patent examination. Retrieved from [URL]
